AGP Picks
View all

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on August 24, 2026

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Blaze Pizza Names Tracy Stockard Chief Marketing Officer
Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes
STMicroelectronics announces status of common share repurchase program
EV Charging Station Market to Grow from USD 3 38.55 billion in 2026 to USD 120.85 billion by 2033 at a CAGR of 17.7%. — MarketsandMarkets™
ASML reports transactions under its current share buyback program
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
Lexis+ with Protégé Accelerates Frictionless Agentic Productivity from First Idea to Review-Ready Legal Work Product
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
Insi Achieves SAP PartnerEdge Sell Status in the United States and Canada, Advancing North American Growth Strategy
Arax-Backed Ashton Thomas Private Wealth Named to Citywire’s 2026 “50 Growers Across America” List
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Blue Jay Gold Announces Nomination of Ashley Kates to the Board of Directors for Upcoming AGM
ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.